Matches in SemOpenAlex for { <https://semopenalex.org/work/W3153133092> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W3153133092 endingPage "281" @default.
- W3153133092 startingPage "272" @default.
- W3153133092 abstract "Background The management of metastatic progressive radioiodine-resistant differentiated thyroid cancer remains challenging for clinicians. The availability of tyrosine kinase inhibitors (TKIs), sorafenib and lenvatinib, within the last decade has expanded treatment options; however, these lead to significant adverse effects, which may curtail their use. Case summary We report the case of a 47-year-old female with Hurthle cell thyroid cancer who underwent total thyroidectomy followed by radioiodine ablation. During follow-up, she developed noniodine-avid renal and pulmonary metastases. With respect to her pre-existing diabetes, hypertension, and polycystic kidney disease, the tumor board decided against performing renal metastasectomy because of the risk of future renal decline requiring dialysis. Metastases were treated using sorafenib, which provided stability followed by progression within a year. We switched to lenvatinib, which led to disease regression. However, the patient experienced severe adverse effects, including cardiomyopathy, bicytopenia, renal impairment, and the rarely reported nephrotic syndrome. Renal metastasis is a rare manifes-tation of Hurthle cell thyroid cancer with only two reported cases in literature. We report the experience of our first case of renal metastasis and its treatment with TKIs. This case serves as a reminder of the adverse drug reactions associated with TKI use. Conclusion We advocate close monitoring of patients' hematological and renal profiles as well as their cardiac status using an echocardiogram." @default.
- W3153133092 created "2021-04-26" @default.
- W3153133092 creator A5005123616 @default.
- W3153133092 creator A5055139400 @default.
- W3153133092 creator A5059291798 @default.
- W3153133092 date "2021-04-24" @default.
- W3153133092 modified "2023-10-16" @default.
- W3153133092 title "Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report" @default.
- W3153133092 cites W1936739249 @default.
- W3153133092 cites W1967792499 @default.
- W3153133092 cites W1981917741 @default.
- W3153133092 cites W1982180772 @default.
- W3153133092 cites W1993360218 @default.
- W3153133092 cites W2028031291 @default.
- W3153133092 cites W2039537505 @default.
- W3153133092 cites W2040642592 @default.
- W3153133092 cites W2089630167 @default.
- W3153133092 cites W2095482730 @default.
- W3153133092 cites W2123598120 @default.
- W3153133092 cites W2149473902 @default.
- W3153133092 cites W2155317003 @default.
- W3153133092 cites W2162031476 @default.
- W3153133092 cites W2168076926 @default.
- W3153133092 cites W2432273922 @default.
- W3153133092 cites W2462504292 @default.
- W3153133092 cites W2560195507 @default.
- W3153133092 cites W2597555201 @default.
- W3153133092 cites W2762326631 @default.
- W3153133092 cites W2762457823 @default.
- W3153133092 cites W2958835124 @default.
- W3153133092 cites W2980520497 @default.
- W3153133092 doi "https://doi.org/10.5306/wjco.v12.i4.272" @default.
- W3153133092 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8085512" @default.
- W3153133092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33959480" @default.
- W3153133092 hasPublicationYear "2021" @default.
- W3153133092 type Work @default.
- W3153133092 sameAs 3153133092 @default.
- W3153133092 citedByCount "1" @default.
- W3153133092 countsByYear W31531330922021 @default.
- W3153133092 crossrefType "journal-article" @default.
- W3153133092 hasAuthorship W3153133092A5005123616 @default.
- W3153133092 hasAuthorship W3153133092A5055139400 @default.
- W3153133092 hasAuthorship W3153133092A5059291798 @default.
- W3153133092 hasBestOaLocation W31531330921 @default.
- W3153133092 hasConcept C121608353 @default.
- W3153133092 hasConcept C126322002 @default.
- W3153133092 hasConcept C126838900 @default.
- W3153133092 hasConcept C143998085 @default.
- W3153133092 hasConcept C197934379 @default.
- W3153133092 hasConcept C2776264508 @default.
- W3153133092 hasConcept C2779761222 @default.
- W3153133092 hasConcept C526584372 @default.
- W3153133092 hasConcept C71924100 @default.
- W3153133092 hasConceptScore W3153133092C121608353 @default.
- W3153133092 hasConceptScore W3153133092C126322002 @default.
- W3153133092 hasConceptScore W3153133092C126838900 @default.
- W3153133092 hasConceptScore W3153133092C143998085 @default.
- W3153133092 hasConceptScore W3153133092C197934379 @default.
- W3153133092 hasConceptScore W3153133092C2776264508 @default.
- W3153133092 hasConceptScore W3153133092C2779761222 @default.
- W3153133092 hasConceptScore W3153133092C526584372 @default.
- W3153133092 hasConceptScore W3153133092C71924100 @default.
- W3153133092 hasIssue "4" @default.
- W3153133092 hasLocation W31531330921 @default.
- W3153133092 hasLocation W31531330922 @default.
- W3153133092 hasOpenAccess W3153133092 @default.
- W3153133092 hasPrimaryLocation W31531330921 @default.
- W3153133092 hasRelatedWork W2161269981 @default.
- W3153133092 hasRelatedWork W2586497158 @default.
- W3153133092 hasRelatedWork W2766131740 @default.
- W3153133092 hasRelatedWork W2788162170 @default.
- W3153133092 hasRelatedWork W2789109497 @default.
- W3153133092 hasRelatedWork W2793991344 @default.
- W3153133092 hasRelatedWork W2996441645 @default.
- W3153133092 hasRelatedWork W3093021181 @default.
- W3153133092 hasRelatedWork W3183971356 @default.
- W3153133092 hasRelatedWork W4367847958 @default.
- W3153133092 hasVolume "12" @default.
- W3153133092 isParatext "false" @default.
- W3153133092 isRetracted "false" @default.
- W3153133092 magId "3153133092" @default.
- W3153133092 workType "article" @default.